×
ADVERTISEMENT

SEPTEMBER 2, 2020

FDA Approves Nonopioid, Drug–Device Treatment Option for Acute Postsurgical Pain Following Hernia Repair

The FDA approved a bupivacaine (Xaracoll, Innocoll) implant for acute postsurgical pain relief for up to 24 hours in adults following open inguinal hernia repair, a painful and commonly performed surgery.